Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs

BACKGROUNDS: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancer types and chemotherapeutic drug resistance is a stumbling block in improving the overall survival of PDAC patients. The nature of specific drug resistant subpopulation within pancreatic ductal adenocarcinoma is bel...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Bangbo, Qin, Cheng, Li, Zeru, Wang, Yuanyang, Li, Tianhao, Cao, Hongtao, Yang, Xiaoying, Li, Tianyu, Wang, Weibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714099/
https://www.ncbi.nlm.nih.gov/pubmed/36457017
http://dx.doi.org/10.1186/s12935-022-02785-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714099/
https://www.ncbi.nlm.nih.gov/pubmed/36457017
http://dx.doi.org/10.1186/s12935-022-02785-7

Ejemplares similares